Abstract
Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have